Re-Engineering Clinical Trials

Best Practices for Streamlining the Development Process

Nonfiction, Health & Well Being, Medical, Reference, Research, Medical Science, Pharmacology
Cover of the book Re-Engineering Clinical Trials by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128007907
Publisher: Elsevier Science Publication: December 16, 2014
Imprint: Academic Press Language: English
Author:
ISBN: 9780128007907
Publisher: Elsevier Science
Publication: December 16, 2014
Imprint: Academic Press
Language: English

The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness.

  • Highlights the latest paradigm-shifts and innovation advances in clinical research
  • Offers easy-to-find best practice sections, lists of current literature and resources for further reading and useful solutions to day-to-day problems in current drug development
  • Discusses important topics such as safety profiling, data mining, site monitoring, change management, increasing development costs, key performance indicators and much more
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness.

More books from Elsevier Science

Cover of the book Raising Entrepreneurial Capital by
Cover of the book Fungal Genomics by
Cover of the book The Yeasts by
Cover of the book Handbook of Grape Processing By-Products by
Cover of the book Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders by
Cover of the book Radiation Biophysics by
Cover of the book Business Modeling by
Cover of the book Biomass for Energy in the Developing Countries by
Cover of the book Stable Gas-in-Liquid Emulsions by
Cover of the book Querying XML by
Cover of the book Transforming Your STEM Career Through Leadership and Innovation by
Cover of the book Advanced Mathematical Tools for Control Engineers: Volume 1 by
Cover of the book Digital Libraries and Innovation by
Cover of the book Fundamentals of Weed Science by
Cover of the book Dielectric Phenomena in Solids by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy